Today: June 21, 2018, 8:09 am
  
Health

Sickle Cell Diseases Treatment Market | Size | Share | Forecast 2018 -2024

Sickle Cell Diseases Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Sickle Cell Diseases Treatment Market
Sickle Cell Diseases Treatment Market
PR-Inside.com: 2018-06-14 14:34:29
Sickle Cell Diseases Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024



Sickle cell disease treatment market is driven by the increasing prevalence of sickle cell anaemia in the developed, developing as well as under developed economies. In addition to this unmet needs are highly available, rise in product pipelines for the treatment of SCD is anticipated to pose great demand for the market. Sickle cell disease treatment market is propelled by rising support by the regulatory bodies and government in the form of investments, fast track approvals for the discovery of newer treatments. Sickle cell anaemia treatment market is restrained by slow adoption of treatments due to the cost associated with it, the absence of a permanent cure for this disease and complications associated with treatment.


A sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/sickle-cell-dis ..



Sickle Cell Diseases Treatment Market is segmented on the basis of disease type, therapy, drug class, distribution channel, and geography.

On the basis of disease type, the global sickle cell disease market treatment is segmented as:

• Sickle beta thalassemia

• Sickle hemoglobin C disease

• Sickle cell anemia

• Others

On the basis of therapy, the global sickle cell disease treatment market is segmented as:

• Bone Marrow Transplant

• Blood Transfusion

• Gene Therapy

On the basis of the drug class, the global sickle cell disease treatment market is segmented as:

• Antibiotics

• Analgesics

• Antimetabolite (Hydroxyurea)

• Others

On the basis of the distribution channel, the global sickle cell disease treatment market is segmented as:

• Hospital Pharmacies

• Retail Pharmacies

• Others

To view TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/sickle-cell-dis ..



Burgeoning prevalence of sickle cell disease has expected to drive the market. As per Centre for Disease Control and Prevention, in 2016, about 100,000 individuals in U.S. are affected by the sickle cell diseases. Black or the African Americans are commonly more susceptible to sickle cell diseases. One in thirteen babies who belongs to the black race are born with SCD’s. Researchers has moved ahead to treat SCD by antibiotics to genome level. Researchers from the Stanford School of Medicine corrected the genes successfully which are carrying gene for SCD and transplanted them with the healthy cells. With the help of Clustered Regularly Interspaced Short Palindromic Repeat technique (CRISPR), researchers has replaced the SCD cell genes with one which doesn’t carry those genes. In 2016, Infosys has donated USD 1.11 million for the stem cell research to develop gene therapies for the disorders like haemophilia and sickle cell disease.

Need more information about this report @

www.precisionbusinessinsights.com/market-reports/sickle-cell-dis ..



Based on the geographical regions, global sickle cell diseases treatment market is segmented into Latin America, Europe, North America, the Middle East and Africa, and Asia Pacific. North America is dominating the sickle cell anaemia treatment market due to the increase in activities in R&D, high accessibility of developed healthcare infrastructure, and high reimbursement policies are attributing for the growth of the SCD treatment market in the region. Owing to the high prevalence rate of disease in Asia pacific and African regions is favouring the growth of SCD treatment market. Asia-Pacific is one of the speedy growing market due to the funding of the various industry players for stem cell research

Some of the sickle cell disease treatment providers are Biogen (U.S.), Gamida Cell (Israel), Genetix Pharmaceuticals Inc. (U.S.), Sangamo Biosciences (U.S.), Alnylam Pharmaceuticals, Inc. (U.S.), Acceleron Pharma (U.S.), Global Blood Therapeutics Inc. (U.S.), Emmaus Medical, Inc. (U.S.), Novartis AG (Switzerland) and Bristol-Myers Squibb Company (U.S.).

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/sickle-cell-dis ..

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ www.precisionbusinessinsights.com

Press Information
Precision Business Insights
Kemp House,

152 – 160 City Road,

London EC1V 2NX

satya
marketing lead
+1-866-598-1553
email
www.precisionbusinessinsights.com


# 770 Words
Related Articles
More From The Author
Global Healthcare Facilities Management Market Size 2013 [..]
Global healthcare facilities management market was valued at US$ XX Mn and expected to grow at XX% Compound Annual Growth [..]
Latin America Over The Counter Drugs Market [..]
Latin America Over The Counter (OTC) Drugs Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest [..]
Healthcare Information Systems Market Size 2013 to [..]
Global healthcare information systems market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound [..]
Global Healthcare M2M Market Size 2013 to [..]
Global healthcare M2M market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth [..]
Heart-lung Machines Market Size 2013 to 2017 [..]
Global heart-lung machines market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual [..]
 
More From Health
HKBU scholars invent award-winning medical device for [..]
HONG KONG, June 20, 2018 - (ACN Newswire) - The research team of Hong Kong Baptist University (HKBU) invented a [..]
Blood vessel-forming cells involved in aggressive brain [..]
Targeting cells involved in blood vessel formation could prevent the growth of the most common type of brain tumour. Selangor, [..]
Singapore eDevelopment Announces Corporate and Business Update
SINGAPORE, June 18, 2018 - (ACN Newswire) - The Board of Directors of Singapore eDevelopment Limited ('SeD'; SGX 40V) wishes [..]
Novotech Signs MOU with China Medical University [..]
SYDNEY, AUS, June 12, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum [..]
Regional Dentistry Practice Launches New Informational Website
Mishawaka, IN; June 13, 2018 – Coulter Family Dentistry today announced the complete redesign and relaunch of the practice’s website [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.